Clinical and EEG characteristics of Noopept in mild cognitive impairment of vascular or traumatic origin
Noopept was associated with increased alpha/beta and reduced delta EEG power, interpreted as nonspecific activation/anxiolytic-type changes.
What this study tells us
This is human clinical evidence. Its strength depends on the study design, sample size, comparator, population, duration and the outcome that was actually measured.
Patients with cognitive disturbances after vascular or traumatic brain disease
n=Not stated in abstract
Noopept was associated with increased alpha/beta and reduced delta EEG power, interpreted as nonspecific activation/anxiolytic-type changes.
Russian-language study; no placebo-controlled blinded design established from the abstract.
Need help with terms such as randomized, placebo, endpoint or sample size? Open the glossary →
Key result
Noopept was associated with increased alpha/beta and reduced delta EEG power, interpreted as nonspecific activation/anxiolytic-type changes.